Calcium Gluconate (Calcium Gluconate) Patent Expiration, LOE Window & CMS Spending

Calcium Gluconate (Calcium Gluconate) by Fresenius Kabi: FDA Orange Book LOE 2037-07-25, 6 AB generics, $17.9M 2024 CMS Part D & Medicaid spend, and 2 CA HCAI SB 17 wholesale price filings.

Regulatory & Reimbursement Dimension Verified Value
Consolidated SponsorFresenius Kabi
FDA Application & PathwayN208418 (NDA)
Exclusivity / Cliff HorizonLong-Dated Protection (2036+)
Core Active-Ingredient LOE DateNot listed / N/A
Last Listed Patent or Exclusivity Date2037-07-25
Orange Book Patents (*PED Extensions)1 patents (0 *PED)
Active AB-Rated Generic Competitors6
2024 CMS Total Public Spend$17.9M
2024 Medicare Part D Spend$62K
2024 Medicaid Spend$17.8M
Reported Wholesale Price Change (CA SB 17)2 WAC filings (max 19.9% 2-yr change)

Related Filings Across Meru Platforms

Verified cross-ledger federal filings for Fresenius / Fresenius Kabi across sibling Meru public-data platforms.